Showing results (51-60 of 91) with videos related to
Sort By:
Pageof 10
International Journal of Cancer|September 9, 2011
Fibronectin attachment protein from bacillus Calmette-Guerin as targeting agent for bladder tumor cellsBrian G Coon, Scott Crist, Andrés M González-Bonet, et al.Journal of Endourology Case Reports|November 22, 2016
Novel Use of Folate-Targeted Intraoperative Fluorescence, OTL38, in Robot-Assisted Laparoscopic Partial Nephrectomy: Report of the First Three CasesCheuk Fan Shum, Clinton D Bahler, Philip S Low, et al.Analytical Chemistry|April 9, 2010
Cholesterol sulfate imaging in human prostate cancer tissue by desorption electrospray ionization mass spectrometryLivia S Eberlin, Allison L Dill, Anthony B Costa, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2012
Cell-intrinsic abrogation of TGF-β signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancerCassie K Chou, Andrea Schietinger, H Denny Liggitt, et al.Frontiers in Oncology|February 11, 2020
Naturally-Occurring Invasive Urothelial Carcinoma in Dogs, a Unique Model to Drive Advances in Managing Muscle Invasive Bladder Cancer in HumansDeborah W Knapp, Deepika Dhawan, José A Ramos-Vara, et al.Molecular Cancer Therapeutics|November 29, 2012
Plk1 phosphorylation of orc2 and hbo1 contributes to gemcitabine resistance in pancreatic cancerBing Song, X Shawn Liu, Steven J Rice, et al.Lab on a Chip|January 6, 2017
Separation and dual detection of prostate cancer cells and protein biomarkers using a microchip deviceWanfeng Huang, Chun-Li Chang, Norman D Brault, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2009
Phase I clinical trial of an adenovirus/prostate-specific antigen vaccine for prostate cancer: safety and immunologic resultsDavid M Lubaroff, Badrinath R Konety, Brian Link, et al.Cell Metabolism|March 11, 2014
Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressivenessShuhua Yue, Junjie Li, Seung-Young Lee, et al.Immunohorizons|December 8, 2022
Monocytic Myeloid-Derived Suppressor Cells from Tumor Tissue Are a Differentiated Cell with Limited Fate PlasticityRyan D Calvert, James C Fleet, Pierrick G J Fournier, et al.Pageof 10